Columbia Suicide Severity Rating Scale (C-SSRS)

Why use it

Provides a structured, reproducible, FDA-endorsed measure of suicide risk that improves consistency across clinicians and settings. Identifies patients at high risk who need immediate intervention. Endorsed by NIMH, FDA, and The Joint Commission for use in clinical and research settings. Separates "ideation" from "behavior" — critically important distinctions for risk management.

About

The Columbia Suicide Severity Rating Scale (C-SSRS) is a standardized, validated, FDA-endorsed instrument for assessing the severity and intensity of suicidal ideation and suicidal behavior. Developed at Columbia University, it provides a structured framework for clinicians to assess and document suicide risk, distinguishing between passive ideation, active ideation (with or without intent and plan), and actual behaviors (aborted, interrupted, actual attempts). The C-SSRS is used in clinical trials, emergency departments, psychiatric settings, and primary care worldwide.

When to use

• Any patient presenting with suicidal ideation, self-harm behavior, or depression
• Emergency department assessment of psychiatric patients
• Screening in primary care for all patients with mood disorders
• Clinical drug trials involving psychiatric medications (FDA requirement)
• Risk stratification before psychiatric discharge
• Serial monitoring of high-risk patients on psychiatric wards

Formula

Pearls & pitfalls

• C-SSRS distinguishes passive suicidal ideation (wishing to be dead) from active ideation (thinking about killing oneself) — this distinction is clinically critical.
• The presence of a METHOD and INTENT elevates risk substantially — these are the highest ideation scores (4 and 5).
• Suicidal behavior (items 6–10) is coded separately from ideation and carries independent prognostic weight.
• The "Screener" version (2 items) can be used for initial triage in busy clinical settings.
• C-SSRS ideation score ≥ 4 or any behavior score ≥ 1 typically warrants urgent psychiatric evaluation.
• The scale does NOT provide a single threshold for hospitalization — clinical judgment, social support, and access to means must also be considered.
• Document time frame clearly: current (past 24h), recent (past month), or lifetime for each item.
• Always ask about access to lethal means (firearms, medications) regardless of C-SSRS score.

Next steps

No ideation (Score 0): Standard care; monitor. Passive ideation only (Score 1): Safety planning; outpatient psychiatric follow-up. Active ideation without plan/intent (Scores 2–3): Psychiatric evaluation; safety plan; consider hospitalization based on clinical judgment. Active ideation with plan or intent (Scores 4–5): Psychiatric emergency; consider inpatient hospitalization; remove means. Any suicidal behavior (Scores 6–10): Emergency psychiatric evaluation; hospitalization typically indicated; remove means; close monitoring.

Evidence

Posner K et al. (Am J Psychiatry 2011) validated C-SSRS in multiple clinical populations. Demonstrated superior reliability (ICC > 0.90) and validity vs. existing instruments. FDA adopted C-SSRS as the standard for suicidality assessment in clinical trials (2012). Endorsed by The Joint Commission, NIMH, and SAMHSA.

References

1. Posner K et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266-1277. — link
2. Mundt JC et al. Prediction of suicidal behavior in clinical research by lifetime suicidal ideation and behavior ascertained by the Columbia Suicide Severity Rating Scale. J Clin Psychiatry. 2013;74(9):887-893. — link